Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.
Morrison Hodges(Institute of Cardiology), Jeananne Krejci, Gregory Granrud, Richard Asinger(Hennepin Healthcare Research Institute), J. Mark Haugland, Gordon J. Conard, Frank L. Mikell(Hennepin County Medical Center)
Cited by 134
Related Papers
ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary
|Journal of the American College of Cardiology|2001|1.4k
Use of Transesophageal Echocardiography to Guide Cardioversion in Patients with Atrial Fibrillation
|New England Journal of Medicine|2001|954
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)
|Kidney International|2011|928
Stroke with intermittent atrial fibrillation: incidence and predictors during aspirin therapy
|Journal of the American College of Cardiology|2000|670
ST-Segment Elevation in Conditions Other Than Acute Myocardial Infarction
|New England Journal of Medicine|2003|652